SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-116111
Filing Date
2024-10-22
Accepted
2024-10-22 09:00:32
Documents
11
Period of Report
2024-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K evok-20241018.htm   iXBRL 8-K 40437
  Complete submission text file 0000950170-24-116111.txt   151200

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20241018.xsd EX-101.SCH 23903
13 EXTRACTED XBRL INSTANCE DOCUMENT evok-20241018_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 241384813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)